Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print April 14, 2008
DOI: 10.2337/db07-0991

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0991v1
db07-0991v2
57/6/1618    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Braun, M.
Right arrow Articles by Rorsman, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braun, M.
Right arrow Articles by Rorsman, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Voltage-gated ion channels in human pancreatic β-cells Electrophysiological characterization and role in insulin secretion

Matthias Braun1, Reshma Ramracheya1, Martin Bengtsson1, Quan Zhang1, Jovita Karanauskaite1, Chris Partridge1, Paul R. Johnson2, and Patrik Rorsman1

1Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK
2Nuffield Department of Surgery, John Radcliffe Hospital, Oxford OX3 9DU, UK

Objective: To characterize the voltage-gated ion channels in human β-cells from non-diabetic donors and their role in glucose-stimulated insulin release.

Research Design and Methods: Insulin release was measured from intact islets. Whole-cell patch-clamp experiments and measurements of cell capacitance were performed on isolated β-cells. The ion channel complement was determined by quantitative PCR.

Results: Human β-cells express two types of voltage-gated K+-currents that flow through delayed rectifying (KV2.1/2.2) and large-conductance Ca2+-activated (BK) K+-channels. Blockade of BK-channels (using iberiotoxin) increased action potential amplitude and enhanced insulin secretion by 70% whereas inhibition of KV2.1/2.2 (with stromatoxin) was without stimulatory effect on electrical activity and secretion. Voltage-gated TTX-sensitive Na+-currents (NaV1.6/1.7) contribute to the upstroke of action potentials. Inhibition of Na+-currents with TTX reduced glucose-stimulated (6–20 mM) insulin secretion by 55–70%. Human β-cells are equipped with L- (CaV1.3), P/Q- (CaV2.1) and T- (CaV3.2), but not N- or R-type Ca2+-channels. Blockade of L-type channels abolished glucose-stimulated insulin release while inhibition of T- and P/Q-type Ca2+-channels reduced glucose-induced (6 mM) secretion by 60–70%. Membrane potential recordings suggest that L- and T-type Ca2+-channels participate in action potential generation. Blockade of P/Q-type Ca2+-channels suppressed exocytosis (measured as an increase in cell capacitance) by >80% whereas inhibition of L-type Ca2+-channels only had a minor effect.

Conclusions: Voltage-gated T-type and L-type Ca2+-channels as well as Na+-channels participate in glucose-stimulated electrical activity and insulin secretion. Ca2+-activated BK-channels are required for rapid membrane repolarisation. Exocytosis of insulin-containing granules is principally triggered by Ca2+ influx through P/Q- type Ca2+-channels.


Correspondence: matthias.braun{at}drl.ox.ac.uk


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.